Health Care M&A Deals, August 28, 2020
The Health Care M&A deals chart is a selection of transactions announced during the prior week(s). The M&A transactions presented here are from our Deal Search Online database, which is updated daily to provide our subscribers with the most up-to-date information and trends in the healthcare industry. The largest deal of the week is Royal Philips’ acquisition of Intact Vascular, Inc. for $360 million. Intact Vascular will enhance Philips’ image-guided therapy portfolio, combining Philips’ interventional imaging platform and diagnostic and therapeutic devices with Intact Vascular’s unique, specialized implantable device to optimize the treatment of patients with Peripheral... Read More »
Health Care M&A Deals, August 21, 2020
The Health Care M&A deals chart is a selection of transactions announced during the prior week(s). The M&A transactions presented here are from our Deal Search Online database, which is updated daily to provide our subscribers with the most up-to-date information and trends in the healthcare industry. The largest deal of the week is Johnson & Johnson’s $6.5 billion acquisition of Momenta Pharmaceuticals, Inc., which provides an opportunity for JNJ to broaden its portfolio in immune-mediated diseases and autoantibody-driven diseases. To subscribe to our Health Care M&A deals chart and more, visit our membership... Read More »
Health Care M&A Deals, August 14, 2020
The Health Care M&A deals chart is a selection of transactions announced during the prior week(s). The M&A transactions presented here are from our Deal Search Online database, which is updated daily to provide our subscribers with the most up-to-date information and trends in the healthcare industry. The largest deal of the week is Bayer AG’s $425 million acquisition of KaNDy Therapeutics Ltd., which will give Bayer KaNDy’s NT-814, a potentially first in class receptor antagonist which showed positive findings for the treatment of moderate to severe vasomotor symptoms due to menopause. To subscribe to our Health Care M&A deals chart and more,... Read More »
Health Care M&A Deals, August 7, 2020
The Health Care M&A deals chart is a selection of transactions announced during the prior week(s). The M&A transactions presented here are from our Deal Search Online database, which is updated daily to provide our subscribers with the most up-to-date information and trends in the healthcare industry. The largest deal of the week was Teladoc Health, Inc.’s (NYSE: TDOC) acquisition of Livongo Health, Inc. (NASDAQ: LVGO) for $18.5 billion. The combination creates a global leader in consumer-centered virtual care. To subscribe to our Health Care M&A deals chart and more, visit our membership site. HealthCareMandA.com is devoted to healthcare merger and acquisition data for... Read More »
Health Care M&A Deals, July 31, 2020
The Health Care M&A deals chart is a selection of transactions announced during the prior week(s). The M&A transactions presented here are from our Deal Search Online database, which is updated daily to provide our subscribers with the most up-to-date information and trends in the healthcare industry. The largest deal of the week is a global development and commercialization agreement for DS-1062 between AstraZeneca plc and Daiichi Sankyo Company valued at $1 billion. DS-1062 is Daiichi Sankyo’s proprietary trophoblast cell-surface antigen 2 (TROP2)-directed antibody-drug conjugate (ADC), and potential new medicine for the treatment of multiple tumor types. The companies will... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
